Analysts' Actions: APOL CLF COG GIS VMW

TheStreet.com

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Federal Agricultural Mortgage was downgraded to sell at TheStreet Ratings.

Ampco-Pittsburgh was upgraded to buy at TheStreet Ratings.

Apollo was downgraded at Wells Fargo to market perform from outperform. Estimates were also cut, as the company is closing more campuses, Wells Fargo said.

Cliffs Natural was downgraded at Morgan Stanley to underweight. $14 price target. Iron ore business will likely be cut in half in the coming years, Morgan Stanley said.

Cliffs Natural was upgraded at Goldman Sachs to neutral from sell. Valuation call, based on a $20 price target, Goldman said.

Cabot Oil & Gas was initiated with a hold rating at Topeka Capital. Valuation call, based on a $74 price target, Topeka Capital said.

Charles River Laboratories was downgraded at Wells Fargo to market perform. Share gains are priced in and valuation is full, Wells Fargo said. Estimates were reduced due to foreign exchange headwinds, Wells Fargo added. Price target is reduced to $42.

DSW were upgraded to buy from hold at Citigroup. Industry-leading square footage growth and gross margin opportunity justify higher multiple. Price target is $74.

General Mills was upgraded at Argus Research to buy from hold. $57 price target. Company is growing faster than its peers but trades at a discount, Argus said.

Ingersoll-Rand was downgraded at J.P. Morgan to neutral from overweight. Valuation call, based on a $53 price target, J.P. Morgan said.

Mastec was initiated with a buy rating at Lazard Capital Markets. $36 price target. Company can deliver above-average growth and expand margins, Lazard Capital Markets said.

Palo Alto was initiated with a buy rating at Needham. $70 price target. Company can continue to attract demand, even in a tight IT spending environment, Needham said.

PG&E was upgraded at Bernstein Research to outperform from market perform. $52 price target.

Pioneer Natural was initiated with a buy rating at Topeka Capital. $158 price target. Company is leveraged to two attractive resource plays, Topeka Capital said.

VMWare was upgraded at ISI Group to strong buy from buy. $115 price target. Company can continue to gain share in server virtualization, ISI Group said.

Viropharma was upgraded at J.P. Morgan to overweight from neutral. $32 price target. Company has a strong pipeline and Cinryze can exceed expectations, J.P. Morgan said.

STOCK COMMENTS/EPS CHANGES

Ashland estimates, target were cut at Jefferies through 2014. Company is seeing weaker end-market demand, Jefferies said. Buy rating and new $92 price target.

BE Aerospace price target and estimates were increased at UBS. Estimates were increased due to the upcoming SFE ramp and modest upside from debt paydown, said UBS. The new price target is $67.

Colfax price target and estimates were increased at UBS to reflect the company's debt refinancing, UBS said. Price target goes to $52.

Cliffs Natural numbers cut at Credit Suisse. Shares are now seen reaching $10. Estimates were also reduced, as pricing can continue to erode in the domestic iron ore business, Credit Suisse said. Underperform rating.

Dr Pepper Snapple Group price target was raised at Citigroup to $53. After meeting with management, Citi said it has increased confidence in its earnings outlook, which justifies a higher premium to the market.

Google estimates and price target were raised at Credit Suisse. Shares are now seen reaching $982. Estimates were also increased, as optimization platforms should help monetize mobile and tablet traffic, Credit Suisse said. Outperform rating.

Kraft Foods numbers were boosted at Canaccord Genuity. Shares are now seen reaching $56. Estimates also upped, as the company is cutting costs, Canaccord said. Buy rating.

Mattress Firm price target and estimates were increased at UBS. Estimates were increased after company provided guidance for fiscal 2013, said UBS. Low-single digit comp increases and 20-60 basis points of adjusted EBIT margin expansion are expected in fiscal 2013, UBS added. Price target goes to $35.

Newell Rubbermaid price target was raised at Oppenheimer. Shares are now seen reaching $30. Company can perform better, after lapping difficult comps, Oppenheimer said. Outperform rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.

View Comments